SAGE Therapeutics is a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-threatening, rare CNS disorders. SAGE's lead program, SAGE-547, is in clinical development for super-refractory status epilepticus and is the first of several compounds the company is developing in its portfolio of potential seizure medicines. SAGE's proprietary chemistry platform has generated multiple new compounds that target GABA A and NMDA receptors, which are broadly accepted as impacting many psychiatric and neurological disorders.
SAGE Therapeutics is a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-threatening, rare CNS disorders. SAGE's lead program, SAGE-547, is in clinical development for super-refractory status epilepticus and is the first of several compounds the company is developing in its portfolio of potential seizure medicines. SAGE's proprietary chemistry platform has generated multiple new compounds that target GABA A and NMDA receptors, which are broadly accepted as impacting many psychiatric and neurological disorders.
Recent Articles
- Countdown to CIIE: Global Businesses Prep for New Opportunities
- Unlocking America’s Mineral Wealth: Insights from a Pentagon Insider
- Reviving Lost Crypto: The Journey of a Bitcoin Recovery Expert
- Brittany Force Achieves Historic NHRA Speed Record of 343.16 MPH
- Reza Pahlavi Reports Surge in Support from Iranian Defectors
- Sling Pilot Academy Joins Forces with Sallie Mae for Financing
- Expansion of Precision Global Corporation with CubeSmart Partnership
- Precision Global Corporation and CubeSmart Join Forces for Growth
- Trump's Administration Investments: A Long-Term Shift in Strategy
- Robert Kiyosaki Compares ETFs to Pictures of Guns, Advocates for Real Assets
- Justice Department's Decision Sparks Controversy Over Attorney Dismissal
- Elon Musk's Surprising View on AI and Rising Birth Rates
- How the Wealthy Diversify: Watches, Diamonds, and the Rise of Collectible Assets
- Independent Voter Sentiment Shifts Significantly for Trump
- Massive Bitcoin Movement Shakes Crypto Markets After Years
- Senator Lummis Advocates Bitcoin: A Vision for Economic Freedom
- TDECU and C.J. Stroud Unite to Promote Financial Literacy
- Dogecoin's Potential Surge: A Historic Buying Opportunity
- Revolutionizing Startup Software Development with AI Solutions
- Secure Your Rights: Join WAMCO Class Action Lawsuit Today
- GeneDx Holdings Corp: Investigating Investor Rights Concerns
- Rosen Law Firm Invites Investors in Rocket Pharmaceuticals to Act
- Donald Trump's Scottish Visit: Golf, Legacy, and Diplomacy
- From Credit Dips to Dividend Tips: When an Online Loan Makes Sense
- Understanding the Pink Salt Trend and Its Health Implications
- WeRide and Chery Join Forces to Launch Global Robotaxi Services
- Investor Challenges Tencent Music's Acquisition of Ximalaya Inc.
- How To Choose The Right Software Solution For Your Business?
- American Progress: President Trump's Administration Updates
- Unlock Potential with BexBack's 100x Crypto Leverage
- WeRide's New Robotaxi Permit: A Step Towards Smart Mobility
- Jamie Dimon Reflects on Dismissal and Family's Support
- America's Journey to Stardom: Insights from President Trump
- Biohaven Securities Fraud Lawsuit: Join the Action Today
- Injury Lawsuits Can Sink More Than Morale—They Can Tank Your Assets
- Exploring America's Hidden Mineral Rush Beneath the Surface
- Key Developments for Rocket Pharmaceuticals Investors
- Discover the KatuChef Cutting Board: Kitchen Innovation Redefined
- Neogen Corporation Faces Class Action Amid Financial Challenges
- Explore TWOPAGES' Trendsetting Insights for Home Décor in 2025
- Celebrating Coinchange's Growth: A Journey to Institutional Finance
- Unlocking the Future: The Final Hours of Bitcoin Swift Presale
- Bitcoin Swift Set to Conclude Stage 1 Presale with Unique Features
- RxSight, Inc. Investors Have Chance to Lead Class Action Lawsuit
- Anthony Scaramucci Commends Trump's Political Comeback and Insights
- Investigation of National Grid plc Sparks Interest Among Investors
- Transforming Spiritual Guidance: Experience Free Psychic Readings
- Understanding Audifort: The Natural Hearing Solution for 2025
- Investors' Hidden Gems: Stocks Making Waves This Week
- Vestis Corporation Investors Urged to Join Securities Class Action